Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Oral Thin Film Drug Delivery & Manufacturing Market by Type (Oral Thin Film, Transdermal Thin Film, Others (Ocular Thin Film, etc.)), By Application (Hospital Pharmacies, Drug Stores, Retail Pharmacies, E- Commerce) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Oral Thin Film Drug Delivery & Manufacturing Market by Type (Oral Thin Film, Transdermal Thin Film, Others (Ocular Thin Film, etc.)), By Application (Hospital Pharmacies, Drug Stores, Retail Pharmacies, E- Commerce) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 204742 3300 Pharma & Healthcare 377 242 Pages 4.9 (34)
                                          

The global oral thin film drug delivery & manufacturing market is expected to grow at a CAGR of 6.5% during the forecast period, to reach USD 3.2 billion by 2030 from USD 2.1 billion in 2018. The growth of this market is driven by factors such as increasing demand for oral thin films due to their convenience and ease of use, growing preference for self-medication, and rising prevalence of chronic diseases such as diabetes mellitus type II and hypertension among the elderly population. Oral Thin Film Drug Delivery & Manufacturing Market By Type: Oral Thin Film Transdermal Thin Film (Ocular Thin Film). Oral Thin Film Drug Delivery & Manufacturing Market By Application: Hospital Pharmacies Drug Stores Retail Pharmacies Commerce.

Some Of The Growth Factors Of This Market:

  1. Increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases is driving the growth of the Oral Thin Film Drug Delivery & Manufacturing market.
  2. Increasing demand for oral thin film drug delivery systems from pharmaceutical companies is also driving the growth of this market.
  3. The increasing number of mergers and acquisitions in this industry is also driving the growth of this market.
  4. Increasing government funding for research and development activities in developing countries such as India, China, Brazil, Mexico etc, are also driving the growth of this market.

Industry Growth Insights published a new data on “Oral Thin Film Drug Delivery & Manufacturing Market”. The research report is titled “Oral Thin Film Drug Delivery & Manufacturing Market research by Types (Oral Thin Film, Transdermal Thin Film, Others (Ocular Thin Film, etc.)), By Applications (Hospital Pharmacies, Drug Stores, Retail Pharmacies, E- Commerce), By Players/Companies Pfizer, Allergan, Indivior, Solvay, ZIM Laboratories, MonoSol Rx Allergan, Sumitomo Dainippon Pharma, IntelGenx, Novartis, NAL Pharma, Wolters Kluwer”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Oral Thin Film Drug Delivery & Manufacturing Market Research Report

By Type

Oral Thin Film, Transdermal Thin Film, Others (Ocular Thin Film, etc.)

By Application

Hospital Pharmacies, Drug Stores, Retail Pharmacies, E- Commerce

By Companies

Pfizer, Allergan, Indivior, Solvay, ZIM Laboratories, MonoSol Rx Allergan, Sumitomo Dainippon Pharma, IntelGenx, Novartis, NAL Pharma, Wolters Kluwer

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

242

Number of Tables & Figures

170

Customization Available

Yes, the report can be customized as per your need.


Global Oral Thin Film Drug Delivery & Manufacturing Industry Outlook


Global Oral Thin Film Drug Delivery & Manufacturing Market Report Segments:

The global Oral Thin Film Drug Delivery & Manufacturing market is segmented on the basis of:

Types

Oral Thin Film, Transdermal Thin Film, Others (Ocular Thin Film, etc.)

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital Pharmacies, Drug Stores, Retail Pharmacies, E- Commerce

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Pfizer
  2. Allergan
  3. Indivior
  4. Solvay
  5. ZIM Laboratories
  6. MonoSol Rx Allergan
  7. Sumitomo Dainippon Pharma
  8. IntelGenx
  9. Novartis
  10. NAL Pharma
  11. Wolters Kluwer

Global Oral Thin Film Drug Delivery & Manufacturing Market Overview


Highlights of The Oral Thin Film Drug Delivery & Manufacturing Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Oral Thin Film
    2. Transdermal Thin Film
    3. Others (Ocular Thin Film, etc.)
  1. By Application:

    1. Hospital Pharmacies
    2. Drug Stores
    3. Retail Pharmacies
    4. E- Commerce
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Oral Thin Film Drug Delivery & Manufacturing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Oral Thin Film Drug Delivery & Manufacturing Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Oral thin film drug delivery & manufacturing is a process that uses films to deliver medications to the mouth. The films are placed on the tongue or other areas of the oral cavity, and then swallowed. This method is often used for medications that need to be taken orally, such as antibiotics or painkillers.

Some of the key players operating in the oral thin film drug delivery & manufacturing market are Pfizer, Allergan, Indivior, Solvay, ZIM Laboratories, MonoSol Rx Allergan, Sumitomo Dainippon Pharma, IntelGenx, Novartis, NAL Pharma, Wolters Kluwer.

The oral thin film drug delivery & manufacturing market is expected to grow at a compound annual growth rate of 6.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Oral Thin Film Drug Delivery & Manufacturing Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Oral Thin Film Drug Delivery & Manufacturing Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Oral Thin Film Drug Delivery & Manufacturing Market - Supply Chain
   4.5. Global Oral Thin Film Drug Delivery & Manufacturing Market Forecast
      4.5.1. Oral Thin Film Drug Delivery & Manufacturing Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Oral Thin Film Drug Delivery & Manufacturing Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Oral Thin Film Drug Delivery & Manufacturing Market Absolute $ Opportunity

5. Global Oral Thin Film Drug Delivery & Manufacturing Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Oral Thin Film Drug Delivery & Manufacturing Market Size and Volume Forecast by Type
      5.3.1. Oral Thin Film
      5.3.2. Transdermal Thin Film
      5.3.3. Others (Ocular Thin Film, etc.)
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Oral Thin Film Drug Delivery & Manufacturing Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Oral Thin Film Drug Delivery & Manufacturing Market Size and Volume Forecast by Application
      6.3.1. Hospital Pharmacies
      6.3.2. Drug Stores
      6.3.3. Retail Pharmacies
      6.3.4. E- Commerce
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Oral Thin Film Drug Delivery & Manufacturing Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Oral Thin Film Drug Delivery & Manufacturing Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Oral Thin Film Drug Delivery & Manufacturing Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Oral Thin Film Drug Delivery & Manufacturing Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Oral Thin Film Drug Delivery & Manufacturing Demand Share Forecast, 2019-2026

9. North America Oral Thin Film Drug Delivery & Manufacturing Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Oral Thin Film Drug Delivery & Manufacturing Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Oral Thin Film Drug Delivery & Manufacturing Market Size and Volume Forecast by Application
      9.4.1. Hospital Pharmacies
      9.4.2. Drug Stores
      9.4.3. Retail Pharmacies
      9.4.4. E- Commerce
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Oral Thin Film Drug Delivery & Manufacturing Market Size and Volume Forecast by Type
      9.7.1. Oral Thin Film
      9.7.2. Transdermal Thin Film
      9.7.3. Others (Ocular Thin Film, etc.)
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Oral Thin Film Drug Delivery & Manufacturing Demand Share Forecast, 2019-2026

10. Latin America Oral Thin Film Drug Delivery & Manufacturing Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Oral Thin Film Drug Delivery & Manufacturing Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Oral Thin Film Drug Delivery & Manufacturing Market Size and Volume Forecast by Application
      10.4.1. Hospital Pharmacies
      10.4.2. Drug Stores
      10.4.3. Retail Pharmacies
      10.4.4. E- Commerce
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Oral Thin Film Drug Delivery & Manufacturing Market Size and Volume Forecast by Type
      10.7.1. Oral Thin Film
      10.7.2. Transdermal Thin Film
      10.7.3. Others (Ocular Thin Film, etc.)
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Oral Thin Film Drug Delivery & Manufacturing Demand Share Forecast, 2019-2026

11. Europe Oral Thin Film Drug Delivery & Manufacturing Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Oral Thin Film Drug Delivery & Manufacturing Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Oral Thin Film Drug Delivery & Manufacturing Market Size and Volume Forecast by Application
      11.4.1. Hospital Pharmacies
      11.4.2. Drug Stores
      11.4.3. Retail Pharmacies
      11.4.4. E- Commerce
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Oral Thin Film Drg Delivery & Manufacturing Market Size and Volume Forecast by Type
      11.7.1. Oral Thin Film
      11.7.2. Transdermal Thin Film
      11.7.3. Others (Ocular Thin Film, etc.)
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Oral Thin Film Drug Delivery & Manufacturing Demand Share, 2019-2026

12. Asia Pacific Oral Thin Film Drug Delivery & Manufacturing Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Oral Thin Film Drug Delivery & Manufacturing Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Oral Thin Film Drug Delivery & Manufacturing Market Size and Volume Forecast by Application
      12.4.1. Hospital Pharmacies
      12.4.2. Drug Stores
      12.4.3. Retail Pharmacies
      12.4.4. E- Commerce
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Oral Thin Film Drug Delivery & Manufacturing Market Size and Volume Forecast by Type
      12.7.1. Oral Thin Film
      12.7.2. Transdermal Thin Film
      12.7.3. Others (Ocular Thin Film, etc.)
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Oral Thin Film Drug Delivery & Manufacturing Demand Share, 2019-2026

13. Middle East & Africa Oral Thin Film Drug Delivery & Manufacturing Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Oral Thin Film Drug Delivery & Manufacturing Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Oral Thin Film Drug Delivery & Manufacturing Market Size and Volume Forecast by Application
      13.4.1. Hospital Pharmacies
      13.4.2. Drug Stores
      13.4.3. Retail Pharmacies
      13.4.4. E- Commerce
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Oral Thin Film Drug Delivery & Manufacturing Market Size and Volume Forecast by Type
      13.7.1. Oral Thin Film
      13.7.2. Transdermal Thin Film
      13.7.3. Others (Ocular Thin Film, etc.)
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Oral Thin Film Drug Delivery & Manufacturing Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Oral Thin Film Drug Delivery & Manufacturing Market: Market Share Analysis
   14.2. Oral Thin Film Drug Delivery & Manufacturing Distributors and Customers
   14.3. Oral Thin Film Drug Delivery & Manufacturing Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Pfizer
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Allergan
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Indivior
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Solvay
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. ZIM Laboratories
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. MonoSol Rx Allergan
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Sumitomo Dainippon Pharma
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. IntelGenx
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Novartis
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. NAL Pharma
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Wolters Kluwer
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us